PFIZER SAYS DISMISSAL OF FRAUD SUIT OVER ARTHRITIS DRUGS SHOULD STAND Teachers' Ret. Sys. of La. v. Pfizer Inc. | Secondary Sources | Westlaw

PFIZER SAYS DISMISSAL OF FRAUD SUIT OVER ARTHRITIS DRUGS SHOULD STAND Teachers' Ret. Sys. of La. v. Pfizer Inc. | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, PFIZER SAYS DISMISSAL OF FRAUD SUIT OVER ARTHRITIS DRUGS SHOULD STAND Teachers' Ret. Sys. of La. v. Pfizer Inc., Secondary Sources
Skip Page Header

PFIZER SAYS DISMISSAL OF FRAUD SUIT OVER ARTHRITIS DRUGS SHOULD STAND Teachers' Ret. Sys. of La. v. Pfizer Inc.

30 No. 18 WJCODL 9By Michael Nordskog, Senior Content Writer, Westlaw Daily BriefingWestlaw Journal Corporate Officers & Directors Liability (Approx. 4 pages)

PFIZER SAYS DISMISSAL OF FRAUD SUIT OVER ARTHRITIS DRUGS SHOULD STAND Teachers' Ret. Sys. of La. v. Pfizer Inc.

30 No. 18 WJCODL 9By Michael Nordskog, Senior Content Writer, Westlaw Daily BriefingWestlaw Journal Corporate Officers & Directors Liability (Approx. 4 pages)

30 No. 18 Westlaw Journal Corporate Officers & Directors Liability 9
Westlaw Journal Corporate Officers & Directors Liability
*1 March 9, 2015
Securities Fraud
By Michael Nordskog, Senior Content Writer, Westlaw Daily Briefing
Copyright © 2015 Thomson Reuters .

PFIZER SAYS DISMISSAL OF FRAUD SUIT OVER ARTHRITIS DRUGS SHOULD STAND

Teachers' Ret. Sys. of La. v. Pfizer Inc.

Briefs and Other Related Documents
Pfizer Inc. has asked a federal appeals court to uphold a Manhattan federal judge's recent dismissal of a decade-old securities fraud lawsuit over safety risks associated with the arthritis drugs Celebrex and Bextra.
Teachers' Retirement System of...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.